StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.35+0.01 (+2.91%)

Close on Nov 18, 2026Market cap $3.05MP/E 0.3Yield –

Evogene net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$8.49M. The highest annual figure on record is -$8.49M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.49M–
FY2024Dec 31, 2024-$16.49M–
FY2023Dec 31, 2023-$23.88M–
FY2022Dec 31, 2022-$26.64M–
FY2021Dec 31, 2021-$27.79M–
FY2020Dec 31, 2020-$23.37M–
FY2019Dec 31, 2019-$18.11M–
FY2018Dec 31, 2018-$20.76M–
FY2017Dec 31, 2017-$20.84M–
FY2016Dec 31, 2016-$19.59M–

More Evogene figures

See a number that looks wrong?